NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDEntrectinib Rozlytrek®
(100 mg and 200 mg hard capsules) 		Malignant disease and immunosuppression, Other antineoplastic drugs, 08.01.05
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Entrectinib Entrectinib [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Protein Kinase Inhibitors
Targeted Therapy Responsive Malignancy
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA1118: Entrectinib for treating NTRK fusion-positive solid tumours in people 12 years and over (TERMINATED APPRAISAL)
NICE TA643: Entrectinib for treating ROS1-positive advanced non-small-cell lung cancer
NICE TA644: Entrectinib for treating NTRK fusion-positive solid tumours (replaced by TA1118)